New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
10:12 EDTNVGNNovogen Limited halted for volatility after jumping 83% to $4.24
News For NVGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 24, 2015
07:03 EDTNVGNNovogen announces Anisini on track to enter clinic in 2016
Novogen announced that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals, the result of which it now has been fast-tracked by the Company to come into the clinic. Anisina targets the cytoskeleton of cancer cells. This is the same target of the most widely used chemotherapy drugs in cancer, the taxanes and vinca alkaloids. Beyond these approved uses, they are widely used off-label across most forms of cancers following failure of standard of care drugs. There remains a significant clinical need to improve on both the efficacy and safety of these commonly used drugs. Novogen believes that Anisina has the features to meet that need across a range of cancer types.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use